Just Do It—Incorporating What We Know into What We Do
Monday, June 24, at 1:30 p.m. ET
Room W315
Orange County Convention Center
EHR-Based Tools to Overcome Therapeutic Inertia and Improve Health Equity in Diabetes Technology Prescriptions
Brittany S. Bruggeman, MD
Assistant Professor of Pediatric Endocrinology,
University of Florida
What is your presentation about?
In previous research, diabetes provider-level barriers prevented underserved patients from adopting diabetes technologies (ie, CGMs and insulin pumps). In our research, we interviewed providers to hear from their perspective what prevents them from prescribing these technologies. Providers most commonly reported that bureaucratic and systematic barriers such as difficulty in determining insurance coverage, DME versus pharmacy benefits, and the cost of devices were prohibitive. They supported the idea of a Diabetes Technology Dashboard within the electronic health record (EHR), in which they would receive prescription performance feedback and have clinical decision support tools to aid in diabetes technology prescriptions.
How do you hope your presentation will impact diabetes research or care?
Diabetes providers are stretched thin and face many bureaucratic barriers to overcoming therapeutic inertia, even when they know that a new therapy is in a patient’s best interest. We hope that our research will demonstrate the systematic barriers that providers face in prescribing diabetes technologies and will promote pragmatic solutions.
How did you become involved with this area of diabetes research or care?
As a pediatric endocrinologist, I see every day how CGMs and insulin pumps help my patients to lower the burden of diabetes management in their day to day lives. However, I also see the many barriers that patients and providers face in accessing these technologies. I became involved in this research to try to address some of these multi-level barriers.
The Michigan Collaborative for Type 2 Diabetes
Lauren Oshman, MD, MPH, FAAFP, Diplomate ABOM
Associate Professor of Family Medicine,
University of Michigan Medical School
What is your presentation about?
Is it possible to coordinate more than 300 primary care and specialty care practices from different health systems across the state of Michigan to improve quality for type 2 diabetes? By listening to the needs of clinicians and their patients and using trusted data and user-centered design and creative QI efforts, we are doing just that at the Michigan Collaborative for Type 2 Diabetes.
How do you hope your presentation will impact diabetes research or care?
We’ll share how we structure and function to improve diabetes care, some challenges we’ve solved, and our hopes for the future.
How did you become involved with this area of diabetes research or care?
The Michigan Collaborative for Type 2 Diabetes was founded in 2020.